These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 1758464)

  • 41. Parkinson's disease: making the diagnosis, selecting drug therapies.
    Scharre DW; Mahler ME
    Geriatrics; 1994 Oct; 49(10):14-6, 20-3. PubMed ID: 7926845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Levodopa: the story continues].
    Titova NV; Katunina EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(9):93-9. PubMed ID: 25473661
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Advanced course of Parkinson disease. Little improved motion with continuous intestinal levodopa administration].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2005 Jul; 28(7):245-6. PubMed ID: 16038123
    [No Abstract]   [Full Text] [Related]  

  • 44. Successful orchestration of antiparkinsonian pharmacotherapy.
    Scheife RT
    Pharmacotherapy; 1999 Nov; 19(11 Pt 2):180S-6S. PubMed ID: 10555946
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amantadine-induced "vocal" myoclonus.
    Pfeiffer RF
    Mov Disord; 1996 Jan; 11(1):104-6. PubMed ID: 8771080
    [No Abstract]   [Full Text] [Related]  

  • 46. Complex dystonia of Parkinson's disease: clinical features and relation to plasma levodopa profile.
    McHale DM; Sage JI; Sonsalla PK; Vitagliano D
    Clin Neuropharmacol; 1990 Apr; 13(2):164-70. PubMed ID: 2328507
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Jejunitis secondary to Duodopa® probe, a different complication.
    Magaz Martínez M; Martínez Porras JL; Oliva B; Abreu L
    Rev Esp Enferm Dig; 2016 Dec; 108(12):815-816. PubMed ID: 27931110
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Levodopa-responsive rubral (Holmes') tremor.
    Vélez M; Cosentino C; Torres L
    Mov Disord; 2002 Jul; 17(4):741-2. PubMed ID: 12210864
    [No Abstract]   [Full Text] [Related]  

  • 49. [Continuous dopaminergic stimulation by Duodopa in advanced Parkinson's disease: Efficacy and safety].
    Annic A; Devos D; Seguy D; Dujardin K; Destée A; Defebvre L
    Rev Neurol (Paris); 2009; 165(8-9):718-27. PubMed ID: 19150100
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dyskinesias during levodopa-carbidopa intestinal gel (LCIG) infusion: Management inclinical practice.
    Melgari JM; Salomone G; di Biase L; Marano M; Scrascia F; Di Lazzaro V
    Parkinsonism Relat Disord; 2015 Mar; 21(3):327-8. PubMed ID: 25595317
    [No Abstract]   [Full Text] [Related]  

  • 51. Drugs for parkinsonism.
    Med Lett Drugs Ther; 1986 Jun; 28(716):62-4. PubMed ID: 3713639
    [No Abstract]   [Full Text] [Related]  

  • 52. Trichophagia affects response to duodenal levodopa/carbidopa gel administration.
    Müller T; Haas T; Lütge S; Marg M; Ehret R
    Mov Disord; 2012 Apr; 27(4):588-90. PubMed ID: 22287105
    [No Abstract]   [Full Text] [Related]  

  • 53. Sinemet in Parkinson's disease: efficacy with and without food.
    Bozek CB; Suchowersky O; Purves S; Calne S; Calne DB
    Clin Neuropharmacol; 1986; 9(2):196-9. PubMed ID: 3708604
    [No Abstract]   [Full Text] [Related]  

  • 54. Off-period screaming accompanying motor fluctuations in Parkinson's disease.
    Steiger MJ; Quinn NP; Toone B; Marsden CD
    Mov Disord; 1991; 6(1):89-90. PubMed ID: 2005932
    [No Abstract]   [Full Text] [Related]  

  • 55. Managing pathological gambling in Parkinson's disease with enteral levodopa/carbidopa infusions.
    Gerschlager W; Bloem BR
    Mov Disord; 2009 Sep; 24(12):1858-60. PubMed ID: 19514056
    [No Abstract]   [Full Text] [Related]  

  • 56. Double-blind controlled study of pergolide mesylate as an adjunct to Sinemet in the treatment of Parkinson's disease.
    Olanow CW; Alberts MJ
    Adv Neurol; 1987; 45():555-60. PubMed ID: 3548266
    [No Abstract]   [Full Text] [Related]  

  • 57. Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa.
    Gawel M; Riopelle R; Libman I; Bouchard S
    Adv Neurol; 1987; 45():535-8. PubMed ID: 3548263
    [No Abstract]   [Full Text] [Related]  

  • 58. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sinemet.
    Drug Ther Bull; 1974 Oct; 12(21):83-4. PubMed ID: 4617660
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of Parkinson's disease.
    Boyson SJ
    Neurology; 1990 Apr; 40(4):725. PubMed ID: 2320258
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.